Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.
Journal Information
Full Title: J Gastroenterol
Abbreviation: J Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestKM has received grants and personal fees from AbbVie Inc., EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Janssen Pharmaceutical K.K., JIMRO Co., Ltd., and KYORIN Pharmaceutical Co., Ltd. HI has received personal fees from Janssen Pharmaceutical K.K. and Mitsubishi Tanabe Pharma Corporation. TN has received personal fees from Alexion Pharma GK., Baxter Ltd., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co., Ltd., DENTSU Inc., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Nikkei Business Publications, Inc., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sumitomo Dainippon Pharma Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; and other remuneration from HANSHIN Dispensing Holding Co., Ltd., JMDC Inc., Nakagawa Pharmacy Co., Ltd., and Toyota Tsusho All Life Co. YH and AM have received personal fees from Janssen Pharmaceutical K.K. and Mitsubishi Tanabe Pharma Corporation. FH has received personal fees from AbbVie Inc., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. FU has received personal fees from Takeda Pharmaceutical Co., Ltd. NS and YS are employees of Mitsubishi Tanabe Pharma Corporation. TH has received grants and personal fees from AbbVie Inc., JIMRO Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; grants from Otsuka Holdings Co., Ltd.; and personal fees from Aspen Japan K.K., Celltrion Healthcare Co., Ltd., EA Pharma Co., Ltd., Eli Lilly Japan K.K., Ferring Pharmaceuticals Co., Ltd., Gilead Sciences, Inc., Janssen Pharmaceutical K.K., KYORIN Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nichi-Iko Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Conflict of interest KM has received grants and personal fees from AbbVie Inc., EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Janssen Pharmaceutical K.K., JIMRO Co., Ltd., and KYORIN Pharmaceutical Co., Ltd. HI has received personal fees from Janssen Pharmaceutical K.K. and Mitsubishi Tanabe Pharma Corporation. TN has received personal fees from Alexion Pharma GK., Baxter Ltd., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co., Ltd., DENTSU Inc., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Nikkei Business Publications, Inc., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sumitomo Dainippon Pharma Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; and other remuneration from HANSHIN Dispensing Holding Co., Ltd., JMDC Inc., Nakagawa Pharmacy Co., Ltd., and Toyota Tsusho All Life Co. YH and AM have received personal fees from Janssen Pharmaceutical K.K. and Mitsubishi Tanabe Pharma Corporation. FH has received personal fees from AbbVie Inc., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. FU has received personal fees from Takeda Pharmaceutical Co., Ltd. NS and YS are employees of Mitsubishi Tanabe Pharma Corporation. TH has received grants and personal fees from AbbVie Inc., JIMRO Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; grants from Otsuka Holdings Co., Ltd.; and personal fees from Aspen Japan K.K., Celltrion Healthcare Co., Ltd., EA Pharma Co., Ltd., Eli Lilly Japan K.K., Ferring Pharmaceuticals Co., Ltd., Gilead Sciences, Inc., Janssen Pharmaceutical K.K., KYORIN Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nichi-Iko Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., and Takeda Pharmaceutical Co., Ltd."
"Funding This work was supported by Mitsubishi Tanabe Pharma Corporation and Janssen Pharmaceutical K.K."
"This cross-sectional study was conducted using an anonymous web-based questionnaire in patients with UC. The survey period was between 11 May 2020 and 1 June 2020. The study was registered in the University Hospital Medical Information Network (UMIN000040343)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025